Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
RLS Global, a medical healthcare company based in Sweden, and ConvaTec, one of the world's leading advanced wound care companies, have made continued progress with the distribution and commercialisation of ChloraSolv[®], a ground-breaking gentle wound debrider, in Europe.
After intensive market preparation and work with specialist wound experts in the Netherlands, ChloraSolv[®] gel was listed on January 1, 2022 in the Z- index and received a positive recommendation for reimbursement from Zorginstituut Nederland (ZN).
Chlorasolv[®] is already available in other European markets such as the Nordic countries.
Karin Fischer, CEO, RLS Global, said:
"I am very pleased with the registration and positive reimbursement recommendation achieved in the Netherlands. Together with ConvaTec we are focused on accelerating the activities to achieve reimbursement across key European markets".
Sandrine Letellier, VP Global Marketing for ConvaTec Advanced Wound Care, said:
"At ConvaTec we're focused on pioneering trusted medical solutions to improve the lives we touch. Effective debridement is a key step within our Wound Hygiene[TM] Protocol of Care and ChloraSolv[®] brings a new gentle yet effective solution for the management of diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). We shall continue to invest in generating robust clinical and health economic data to illustrate the value we feel the product brings to patients".
ChloraSolv[®], manufactured by RLS Global, is a CE marked wound bed preparation gel intended for cleansing and debridement of the wound[1]. Without damaging the healthy tissue, ChloraSolv[®] ensures fast and easy debridement by softening and making it easy to mechanically remove devitalized tissue, pus and other biological debris that prevents the wound from healing[2,3].
1. ChloraSolv® instructions for use. (https://chlorasolvacademy.se/wp-content/uploads/2021/09/IFU-ChloraSolv-ML-version-2021-09-06.pdf)
2. Berqvist K, Almhöjd U, Herrmann I, Eliasson B. The role of chloramines in treatment of diabetic foot ulcers: an exploratory multicentre randomised controlled trial. Clinical Diabetes and Endocrinology; 2016 2:6
3. Eliasson B, Fagerdahl A, Jönsson A, Apelqvist J. Debriding effect of amino acid-buffered hypochlorite on hard-to-heal wounds covered by devitalised tissue: pilot study. Journal of Wound Care; 2021 30:6;
TRADING PLACE AND CERTIFIED ADVISER
RLS Global's shares have been listed on the Nasdaq First North Growth Market since 17[th] May, 2017 and trading takes place under the short name RLS. Certified Adviser is Redeye Aktiebolag, phone: +46 8 121 576 90, email: certifiedadviser@redeye.se.During the period 2012-2017, the company was listed on Aktietorget.